LENSAR Inc
Research LENSAR Inc (LNSR) on Bullrun: market cap USD 76.39M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLNSR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 76.39M
- Financial periodQ2 2026
- RevenueUSD 16.50M
- Net incomeUSD 3.54M
- Free cash flow-USD 162.00K
- Gross margin59.3%
Valuation Snapshot
latest market cap is USD 76.39M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 51.66M | -USD 34.28M | -USD 14.91M | 39.4% | -2.87 | USD 12.97M | USD 2.74M | -USD 26.02M |
| FY2024 | USD 45.96M | -USD 31.40M | -USD 2.43M | 39.9% | -2.73 | USD 16.26M | USD 2.61M | USD 4.86M |
| FY2023 | USD 35.72M | -USD 14.38M | -USD 9.90M | 41.0% | -1.31 | USD 20.62M | USD 2.31M | USD 33.43M |
| FY2022 | USD 29.44M | -USD 19.91M | -USD 14.97M | 47.7% | -1.96 | USD 14.67M | USD 2.80M | USD 41.98M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 76.39M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 139.48M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 104.19M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 39.48M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 32.63M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 65.83M | n/a | n/a | n/a |
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is LENSAR Inc's market cap?
LENSAR Inc's market capitalization is USD 76.39M.
What does LENSAR Inc do?
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.